{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:36:33Z","timestamp":1793921793937,"version":"4.8.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.urolonc.2022.08.006","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T07:50:04Z","timestamp":1663833004000},"page":"495.e11-495.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0950-1296","authenticated-orcid":false,"given":"Isamu","family":"Tachibana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean Q.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushi S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Adra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Boris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Cary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.urolonc.2022.08.006_bib0001","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.juro.2011.05.051","article-title":"Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?","volume":"186","author":"Delacroix","year":"2011","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2022.08.006_bib0002","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.juro.2010.12.053","article-title":"Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases","volume":"185","author":"Whitson","year":"2011","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.08.006_bib0003","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.eururo.2008.09.052","article-title":"Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881","volume":"55","author":"Blom","year":"2009","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2022.08.006_bib0004","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00345-016-1886-3","article-title":"The rationale and the role of lymph node dissection in renal cell carcinoma","volume":"35","author":"Capitanio","year":"2017","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2022.08.006_bib0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5301\/RU.2012.9255","article-title":"The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma","volume":"79","author":"Capitanio","year":"2012","journal-title":"Urologia"},{"issue":"5","key":"10.1016\/j.urolonc.2022.08.006_bib0006","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bju.14127","article-title":"The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis","volume":"121","author":"Bhindi","year":"2018","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.urolonc.2022.08.006_bib0007","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2016.09.019","article-title":"Radical nephrectomy with or without lymph node dissection for nonmetastatic renal cell carcinoma: a propensity score-based analysis","volume":"71","author":"Gershman","year":"2017","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.08.006_bib0008","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1464-410X.2012.11693.x","article-title":"Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data","volume":"113","author":"Sun","year":"2014","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.urolonc.2022.08.006_bib0009","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.juro.2017.07.042","article-title":"Retroperitoneal lymphadenectomy for high risk, nonmetastatic renal cell carcinoma: an analysis of the ASSURE (ECOG-ACRIN 2805) adjuvant trial","volume":"199","author":"Ristau","year":"2018","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2022.08.006_bib0010","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2016.12.027","article-title":"Renal cell carcinoma with isolated lymph node involvement: long-term natural history and predictors of oncologic outcomes following surgical resection","volume":"72","author":"Gershman","year":"2017","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2022.08.006_bib0011","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMoa2106391","article-title":"Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma","volume":"385","author":"Choueiri","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922003003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922003003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:24:54Z","timestamp":1761042294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143922003003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1078143922003003"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.08.006","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}